Normally, sonic hedgehog (Shh) signaling induces high levels of Patched 1 (Ptc1) and its associated transcription factor Gli1 with genesis of specific neuronal progeny. But their roles in the neural stem cells (NSCs), including glial precursor cells (GPCs), of Alzheimer's disease (AD) are unclear. Here, we show that Ptc1 and Gli1 are significantly deficits in the hippocampus of an aged AD transgenic mouse mode whereas these two molecules are highly elevated at young ages. Our similar findings in autopsied AD brains validate the discovery in AD mouse models. To examined whether A peptides, which are a main component of the amyloid plaques in AD brains, affected Ptc1-Gli1 signaling, we treated GPCs with A peptides, we found that high does of A 1-42 but not A 1-40 , significantly decreased Ptc1-Gli1 while Shh itself was elevated in hippocampal NSCs/GPCs. Furthermore, we found that deficits of Ptc1-Gli1 signaling induced NSCs/GPCs into asymmetric division, which results in an increase in the number of dividing cells including transit-amplifying cells and neuroblasts. These precursor cells commit to apoptosis-like death under the toxic conditions. By this way, adult neural precursor cell pool is exhausted and defective neurogenesis happens in AD brains. Our findings suggest that Ptc1-Gli1 signaling deregulation resulting abnormal loss of GPCs may contribute to a cognition decline in AD brains. The novel findings elucidate a new molecular mechanism of adult NSCs/GPCs on neurogenesis and demonstrate a regulatory role for Ptc1-Gli1 in adult neural circuit integrity of the brain.
INTRODUCTION
Sonic hedgehog (Shh) binds to two Patched (Ptc) proteins, Ptc homolog 1 (Ptc1) and Ptc homolog 2 (Ptc2) with similar high-affinity and inhibits Smo acitivities (1, 2) . Smo triggers a signaling cascade (3) and regulates Gli zinc finger transcription factor, Gli1, Gli2 and Gi3, which have distinct and overlapping functions in response to Shh signaling (4, 5) . Gli1 and Gli2 are then translocated into the nucleus and activate gene transcription and Gli3 acts as a repressor (6) . The balance of Gli functions influences expression of target genes (7) .
Shh acts as a morphogen in embryonic neural development (8, 9) . Once development has been completed, the expression of Shh-mediated signaling molecules declines to low levels in normal healthy brains (10) , maintains the neurogenic niches (11) (12) (13) and controls cell division of neural stem cells (NSCs) or glial precursor cells (GPCs) (14, 15) . The up-regulation of Shh signals is involved in brain stroke (16) and even multiple sclerosis (17) .
The impairment of learning and memory is one of characteristics of Alzheimer's disease (AD), which is associated with the overproduction of amyloid  protein (A) (18, 19) . There are arguments on the exploration of neurogenesis in AD brains (20) (21) (22) (23) . Hippocampal neurogenesis is closely associated with learning and memory. To our knowledge, however, there is still no investigation of Shh signaling and its relationship with neurogenesis in AD brains.
In the present study, we find an increased level of Shh signaling in the hippocampi of APP23 mice and AD patients. Soluble Aβ 
Shh levels are elevated in the hippocampus of APP23 mice
Shh signaling maintains NSC/GPC pool in the hippocampus (11, 15) . To test whether Shh protein levels in the hippocampus were changed in APP23 transgenic mice and if so, whether Shh expression was changed as aging. The hippocampi were dissected from WT and APP23 mice at age of 3, 12 and 24 months old for Shh detection by Western blot. We found three bands of the molecular weights: ~50kD, ~100kD and ~150kD in APP23 mouse brains and aged WT brains (Fig.   1d ). Evidence has shown that ligand Shh is produced as an approximately 20kD N-terminal signaling domain (ShhN) and modified by adding palmitoyl on N-terminal amino acids and cholesterol on carboxyl end (27, 28) . The high molecular weight Shh may be free diffusible and solube multimeric forms of Shh with lipophilic modification(s-ShhNp) (28, 29) . By qualification analysis, we found that Shh expression levels at each molecular weight were significantly elevated at all ages of APP23 mice, compared to age matched WT mice (Fig. 1e) . Due to overdue accumulation of Aβ along with age in APP23 mice (24) , the deregulation of Shh levels is probably associated with the effects of Aβ.
Expressions of Ptc-Gli signaling components are deficits in old AD transgenic mice where these signals are elevated at young ages
Shh-receiving cells exist in the hippocampal formation (11, 15) . It has been known that the application of Shh enhances the signaling component expressions of Shh-responding cells (30, 31) 
.
Whether the elevated Shh level in the hippocampus of APP23 mice was accompanied with a corresponding up-regulation of Shh signaling component molecules was not clear. There are two Shh binding proteins, Patched homolog 1 (Ptc1) and 2 (Ptc2) (1, 32) . Ptc1 is highly expressed in adult hippocampus (10, 33) as well as isolated NSCs/ GPCs (11) . To examine whether the Ptc1 expression level in APP23 mice was changed, immunostaining was first performed with antibody against Ptc1 at 12 months old mice. Results showed an increased expression in the granular cells of dentate gyrus, especially in the cells of hilus region (Fig. 2a) . To further confirm the results from Downloaded from https://academic.oup.com/hmg/article-abstract/23/24/6512/608166 by guest on 18 January 2019 IHC, the hippocampus was dissected from APP23 mice and Ptc1 expression was probed. Western blot showed that the expression levels of Ptc1 had not been significantly elevated at 3 months old yet (Fig. 2b, c) , but greatly increased in the hippocampus at 12 months old APP23 mice (Fig. 2d, e) .
Unexpectedly, the Ptc1 levels were reduced in the hippocampus of 24-month-old APP23 mice (Fig.   2f, g ). Ptc2 has similar and overlapping functions of Ptc1 (1) . Similar to Ptc1 expression pattern, we found that levels of Ptc2 were elevated at 12-month-old and reduced at 24-month-old APP23 mice (Fig. 2b-g ). Smo membrane proteins, which is inhibited by Ptc (34) , are expressed in the normal hippocampus (10, 33) . We tested Smo levels and found that Smo levels were significantly elevated at 3, 12, 24 months old APP23 mice compared to corresponding WT controls ( Fig. 2b-g ). Gli proteins are three types of zinc finger transcription factors, Gli1, Gli2 and Gli3, which have distinct and overlapping functions (5). Gli1 is a canonical transcription factor as a read-out in response to Shh signals (32) , which activates transcription and practice Shh signaling role in hippocampal NSCs (15) . We measured Gli1 expression in the hippocampus and found a significant increase in 12-and 24-month-old APP23 mice (Fig. 2d-g ), still without a significant increase at 3-month-old-APP23 mice (Fig. 2b, c) . Gli2, an activator like as Gli1, is involved in initial Shh response (35) . Similar to the Gli2 expression pattern, we found that expression levels of Gli2 were also greatly elevated in 24-month-old APP23 mice (Fig. 2f-g ), but not be significantly increased at 3 and 12 months of age (Fig. 2b-e) . Gli3, a predominant negative regulator for Shh signaling transcription, is upregulated in the absence of Shh signals (32) . Gli3 was probed by Western blot and results showed a significant decrease in expression levels in 24-month-old APP23 mice (Fig. 2f-g ), but not significant changes at 3 and 12 months of age, compared to corresponding age-matched WT mice (Fig. 2b-e) . Even if a decrease in Ptc levels is observed the expression levels of Gli1 and Gli2 are still elevated. It indicates that the Shh signaling still play a role in hippocampus in aged APP23 mice. These results show that, responsive to increased Shh levels, Shh-receiving cells in hippocampus at younger and aged stage have different responses in APP23 mice. The difference could stem from the changes of cell components in hippocampus at different age stage. To examine whether the elevation of Shh signaling in the hippocampus of APP23 mice reflects the real pathological situation in AD brains, we harvested the hippocampal tissues from both AD (n = 5) and HC samples (n = 5) to examine the expression of Shh signaling. Western blotting study showed an apparent and significant increase in Shh expression levels in of the AD hippocampus compared to the healthy controls ( Fig. 2: h, i) . Interestingly, different from mice with Shh molecular weights of ~50kD, ~100kD and ~150kD, only one obvious band with approximately 50kD was observed in the hippocampus of human beings (Fig. 2h) . Similarly, we found that the expression levels of Ptc1 and Ptc2 were reduced in AD ( Fig. 2: h, i) , counterpart to the observation in 24-month-old APP23 mice.
Next, we tested the expression of Smo and found significantly increased levels of Smo expression in the hippocampus of AD brains (Fig. 2: h, i) , also similar to the findings in 24 months old APP23
mice. Furthermore, we tested the transcription factor proteins Gli1, 2 and 3 and found that both Gli1 and Gli2 protein levels were significantly elevated whereas Gli3 repressor levels were significantly decreased in AD brains (Fig. 2: h, i) . The results indicate that the alteration of Shh signaling in AD brains may be a counterpart of aged (24-month-old) APP23 mice, reflecting an activated Shh signaling in the hippocampus of AD brains.
A 1-42 decrreases Ptc-Gli1 while it elevates Shh signaling in cultured GPCs
NSCs isolated from mouse SVZ secrete Shh proteins in an autocrine fashion (36) and hippocampal GPCs express Shh mRNA (31) . However, whether Shh proteins could be tested from isolated hippocampal GPCs was still not clear. To clarify Shh secretion from the hippocampal GPCs, we isolated GPCs from neonatal WT mice and cultured for 2 weeks. The spheres were dissociated and cultured for another 2 weeks. The conditioned media were collected and the secreted proteins were analyzed. Western blot showed that Shh molecules exist in the cultured media of hippocampal GPCs (Fig. 3a) , suggesting a release of Shh from the cultured NSCs. Expectedly, Shh expression 7 was found in the cell lysate of GPCs (Fig. 3a) . It suggests the hippocampal GPCs could produce Shh protein in an autocrine manner (31) . It has been shown that Aβ 1-42 peptide application increases new neuron production (37, 38) . To exam whether the enhanced differentiation by Aβ peptides would be associated with Shh signaling, the GPCs were treated with Aβ 1-42 for 72 h. The conditioned medium and the cultured cells were harvested. Using Western blot techniques, we found that the levels of Shh expression were elevated in the cultured medium with Aβ 1-42 treatment (Fig. 3a) and in a dose-dependent manner (Fig. 3b) . Similar findings of Shh expression were observed in the GPC lysate and Shh levels were expectedly elevated with Aβ 1-42 incubation in dosedependent manner. A little surprise, the different molecular weights between 37kD and 150kD were observed (Fig. 3a) , similar to the findings in the hippocampi of mice (Fig. 1d) , suggesting the presence of Shh multimer molecule in isolated hippocampal GPCs. A fraction of GPCs is responsive to Shh signal (11, 15) . A previous report showed detectable mRNA levels of Shh signaling components in isolated hippocampal GPCs (31) . Next, we examined the expressions of Shh pathway components. We found apparent increases in Ptc1, Ptc2, Smo, Gli1 and Gli2 expression levels but without significant changes of Gli3 levels in the presence of Aβ (Fig. 3c, d) .
However, the elevation of Ptc1 expression is blocked by Aβ 1-42 application at the high concentration (100 µM) even if Shh levels are still elevated at this dose of Aβ (Fig. 3c, d) . The result that the high dose of A exposure reduces the molecule levels of Ptc1 expression is consistent with the change in the hippocampal formation at 24 months old APP23 mice (Fig. 2f, g ) and in AD patient brains ( Fig. 2: h, i) . It may be an effect of Aβ itself or other factors induced by excessive Aβ in the dysregulation.
It has also been reported that Aβ 1-40 peptide enhances GPC proliferation in vitro (38, 39) . To test whether the increased proliferation is through Shh signaling, we treated the hippocampal GPCs with different doses of Aβ for 72 h. Results showed that there were not significant changes of Shh expression levels in the conditioned medium with various doses of Aβ 1-40 incubation (Fig. 3e, f) .
Similarly, little changes of Shh levels were observed in the GPC lysate treated with Aβ . By using the same approach, we tested the downstream molecules of Shh signaling and found no significant changes in protein levels in the GPCs exposed to Aβ (Fig. 3: g-h) . The results suggest that Aβ 1-40 -induced proliferation may not be associated with Shh signaling. It has been reported that Shh promotes Ptc1 expression levels (3, 30, 31) . To further clarify that the increased expression of Shh pathway components is caused by A  itself or by A  -triggered Shh, we treated the GPCs with Shh molecule for 72 h and found an increased level of Ptc1 expression (Fig. 3: i, j) , suggesting that Aβ-induced Shh level elevation is associated with the level increase of Shh signaling components instead of Aβ itself.
Cell proliferation is altered and Shh signaling blockage prevents an increase in the number of dividing cells in APP23 mice
It has been suggested an increased proliferation in the hippocampus of APP23 mice (20, 39) . To further clarify the possible change in cell proliferation happened in APP23 and WT mice at 3, 12 and 24 months old were injected with BrdU twice a day. The brain sections were analyzed within 24 hr. BrdU-positive cells were visualized by immunostaining and the positive nuclei were primarily showed in SGZ (Fig. 4a) . We found a significant increase of more than two folds in the number of BrdU-positive cells in SGZ of 3-month-old APP23 mice compared to corresponding WT (p < 0.01, (34) and inhibit the proliferation of hippocampal dividing cells (11) . WT and APP23 mice at age of 3 months old were injected with cyclopamine or vehicle alone as reported (11, 34, 40) . One-week injection was followed by twice a day of BrdU injection. After 24 h last BrdU application, immunohistochemistry was performed with antibody against BrdU. The number of mmunopositive nuclei was counted in SGZ. We found that about 40% WT and APP23 mice at this age (Fig. 4e) . These results indicate that the elevation of Shh signaling levels contributes to the altered proliferation in the hippocampus of APP transgenic mice.
Survival of NSCs decreases and apoptotic cell number increases in APP23 mice
It is unknown whether the enhanced cell proliferation at 3-month-old APP23 mice could be in part 
Numbers of GPCs were decreased and astrocytes were increased in APP23 mice
Hippocampal GPCs, a population of GPCs resided in the SGZ of hippocampus, have astroglia-like characteristics expressing GFAP, vimentin, nestin and produce new neurons. The cells, which lack S100β and DCX expression (41, 42) , extend small trees of dendritic-like processes perpendicular to the GCL into the inner molecular layer (43) . A fraction of hippocampal GPCs expressing nestin respond to mitogen Shh (15) . Whether the elevated Shh levels in the hippocampus could increase nestin-positive cells remains to be investigated. To observe the group of nestin + GPCs, GFAP,
another marker for radial glial-like GPCs (42), was immunolabeled together ( (42, 43) . We found the nestin-positive and GFAP-negative immunostaining cells with a short process localized in SGZ and hilus (Fig. 5e ) and a significant decrease in the number of transitamplifying cells (p < 0.01, Fig. 5f ). Mature astrocytes, which are nestin negative and GFAP-positive immunolabeling cells, were observed in hilus of DG (Fig. 5f) . We found that the number of mature astrocytes (nestin -GFAP + ) was significantly increased in 3 months old APP23 mice (p < 0.01, Fig.   5f ). To confirm the astrocytes come from dividing GPCs, the double staining with antibodies against BrdU and GFAP are performed at 12 months old WT and APP23 mice. Results showed a few of double-labeling cells in the hilus (Fig. 5g) , suggesting the increased number of astrocytes might be, at least in part, from dividing GPCs. In addition, the increased astrocyte number might be in part from the activation of dominant astrocytes in responsive to elevated Shh signaling (44) due to few cells of co-labeling BrdU and GAFP.
Defective neurogensis in APP23 mice
After exiting the cell cycle, most of the nascent cells die, and the surviving cells then differentiate into neurons and glia. It has been shown that a fraction of psa-NCAM-positive cells (neuroblast) are
Shh-responding cells (15) . Whether the neuronal commitment of the dividing progenitor cells could be increased in response to the intensified Shh signaling is not clear. Doublecortin (DCX) is another marker for neuroblasts (45, 46) . Immunostaining was performed and results showed a significant increase in number of DCX + cells at 3-month-old whereas a significant decrease in the number at 12-and 24-month-old APP23 mice compared to age-matched WT ( suggesting that increase in the number of dividing cells in part is from the differentiating neuroblasts.
Due to too few double-labeling cells, we did not perform statistical analysis. To observe the fate of the increased neuroblasts at 3-month-old APP23 mice, the mice were detected with double-labeling of BrdU and NeuN (mature neuron marker) after 4 weeks of BrdU application. The NeuN-positive nuclei with BrdU labeling were showed (Fig.6e) . Double labeling cells were counted and results
showed that the average co-labeling cell number is 11.5 ± 1.9 and 5.2 ± 0.7 per section in WT and APP23mice, respectively. Statistical analysis showed a significant decrease in the co-labeling BrdU + NeuN + cells in 3 months old APP23 mice (p < 0.01, Fig. 6g ), suggesting a decrease in the number of neuroblasts to mature neurons due to apoptosis-like cell death (Fig. 6c-f ). 
DISCUSSION

Shh-producing cells
In our current study, it is the first to discover that Shh signaling is greatly elevated in the hippocampal extracts of AD patients and APP23 mice (Fig. 1) . As for the origin of Shh protein in hippocampus, it has been suggested that Shh-producing cells in the basal forebrains anterogradely transport Shh to the hippocampus via the axonal projection (10, 11, 33 (Fig. 3) . Due to the differences of cultured GPCs from that in vivo, Shh production from GPCs still need to be analyzed. Meanwhile, addition of A 
Shh-receiving cells
A fraction of NSCs and their immediate GPCs respond to Shh activity (11, 15) . Our results demonstrate that Shh signaling molecules, Shh-Ptc-Smo-Gli axis, are universally up-regulated in the hippocampus of AD-like APP23 mice ( Fig. 2 and Fig. 7 ). And we find that isolated hippocampal
NSCs express and up-regulate Shh pathway components in the presence of Shh signal (Fig. 7) , which is consistent with a previous report (11, 31) . Here we demonstrated that, in addition to Shh (Fig. 2) , controversial to Ptc level increase at a younger (3 and 12 months of age) stage. Shh and Ptc seem to change earlier (it increases most at 12 months old ( Fig.   1d and Fig. 2d ) than that of insoluble A at 24 months old (Fig. 1c) . 
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APP23 transgenic mice at 3, 12 months of age (Fig. 4 and Fig. 5) . Combining with the data of elevated Shh signaling in AD brains and Shh signaling inhibition by cyclopamine ( Fig. 2 and Fig. 3 ) (11) , it indicates that Shh signaling may be associated with the regulation of GPCs proliferation above basal levels in APP23 brains at young stage. It seems to be consistent with a report that APP23 mice have more neurons until they develop amyloid plaques (51) . Therefore, the increase in the number of dividing cells found at young stage of APP23 brains may present an acceleration of cell division of the resided GPCs in response to the elevation of Shh signaling (Fig. 7) . A large of population of post-mitotic cells commit to death (52) and a small group of differentiation cells can survive and replace dead neurons (Fig. 5) . In AD brains, the existence of constant and high-level Aβ especially toxic soluble Aβ accelerates dividing cells to death (23, 53) . Our observation of increased apoptosis-like in DG of APP23 mice may also reflect more diving cells to death at aged APP23 mice (51) . In addition, due to fast dividing of Shh-responding GPCs, it raises a possibility that the dilution of BrdU levels is beyond detection so that the decrease in the number of dividing cells is observed within 4 weeks (e.g. 90% of dividing cells disappear) in 3-month-old APP23 mice.
We notice a report that there is a discrepancy in cell proliferation in the hippocampus at age 5 and 25 months old of APP23 mice, respectively (20) . The findings are different from our observation here with an increase or decrease in the dividing cell number at age of 3 or 24 months old. It may suggest a different observation method. In that report they applied BrdU for 7 days and immunostaining was performed 3 weeks after the last injection. It is similar with our observation of BrdU staining 4 weeks after the last BrdU application. It indicates a survival change in addition to proliferation.
Defective neurogenesis and increased gliogenesis
Hippocampal NSCs/GPCs are quiescent and can maintain in the state for lifetime (55, 56). In normal adult brains, quiescent NSCs/GPCs are gradually released to exit cell cycle G o and enter the rounds of division at basic level of Shh signal stimulation (15) . Different from the continuous self-renewal of hemapoietic GPCs (54), a recent report show that adult hippocampal GPCs lose the capacity to self-renew and the cell number decreases in an age-dependent manner (Fig. 5) (50) .
Here, we find a great decrease in the number of radial glial-like stem cells in the hippocampus of 3-month-old APP23 mice (Fig. 5 and Fig. 6 ). The GPCs loss indicates that more quiescent GPCs enter dividing cycle and lose their characteristics of GPCs due to high levels of Shh signaling stimulation in AD brains. Still, we cannot exclude the possibility of Aβ toxicity to impair hippocampal quiescent GPCs. It has also been shown that, upon exiting quiescent state, adult hippocampal stem cells rapidly undergo a series of asymmetric divisions to produce dividing progeny destined to become neurons (50) . If it is true in this case, increasing number of stem cells exiting quiescent state may be the reason of an increase in the number of fast-dividing transit-amplifying cells (GFAP-negative and nestin-positive cells) and neuroblasts (DCX-and psa-NCAM-positive cells) we observed here in the hippocampus of 3 months old APP23 mice (Fig. 6) . In addition, transitamplifying cells and neuroblasts self-responding to Shh (15) may also contribute to the dividing cell number observed here in 3-month-old APP23 brains. Meanwhile, the stem cells exiting quiescent state subsequently convert into mature astrocytes by division-coupled astrocytic differentiation (50) .
By this way, an elevated Shh signaling in AD brains contributes to an increase in the cell number of astrocytes originated from neural stem cells, a trend to gliogenesis. Unlike new neurons which are subject to death in response to a detrimental environment, newly generated astrocytes by asymmetric division survive brain disorders (23, 53) . In addition, it also is possible that a fraction of dormant astrocytes responding to elevated Shh levels (44, 47, 54) or Aβ (54) are activated and added the glial cell number in APP23 brains, i.e. a reactive astrogliosis.
In normal adult brains, neural stem cells store in hippocampus. Once injuries happen mitogen signaling such as Shh is elevated (Fig. 7) Table 1 ). The average ages of the HC and AD subjects were 82 ± 15 and 78 ± 7 years old, respectively.
MATERIALS AND METHODS
Animals
5-Bromo-2-deoxyuridine (BrdU) incorporation.
Mice were kept in a normal 12 h light 12 h dark cycle.
BrdU (B5002, Sigma) was prepared in a sterile stock solution of 10 mg/ml dissolved in 0.9% (w/v) NaCl solution. BrdU of 50 mg/kg body weight was intraperitoneally injected twice a day, interval of 4 h, at 3, 12, 24 months old WT and APP23 mice (n = 6 each group). For proliferating analysis, after 24 h of last injection the mice were perfused and brain tissues were collected. For survival and differentiation observation, 3-month-old WT and APP23 mice (n = 6, respectively) were sacrificed and the brain tissues were harvested 4 weeks after last injection.
Cyclopamine injecetion. Cyclopamine specifically blocks Shh signalling by binding to Shh receptor complex Smo (34, 57, 58) . WT and APP23 mice with age of 3 months old were injected intraperitoneally as described previously (11, 44) , with either vehicle [45% 2-hydroxypropyl-β-cyclodextrin (HBC) in sterile phosphate-buffered saline, Sigma] or cyclopamine (C4116, Sigma, 25 mg/kg/day, 1 mg/ml of w/v in 45% HBC) (37) for 7 consecutive days. The day following last injection, all animals were administered with the mitotic marker BrdU (100 mg/kg; Sigma) twice a day with interval of 4 h and were sacrificed 24 h later.
Glial precursor cell (GPC) culture. The hippocampus tissues from neonatant WT mouse (P0-P3)
were isolated under a stereomicroscope. As we previously reported (23), cells were dissociated using papain/DNase I (Vector Laboratories, CA) and cultured in flasks that were pre-coated with 10 mg/ml poly(2-hydroxyethyl methacrylate) (P3932, Sigma) to avoid cell adhesion (31) . Primary neurospheres were generated in DMEM/F12 medium (growth medium) containing 10 ng/ml of bFGF ELISA. Aβ ELISA was performed as described previously (23, 26) . In brief, Wild-type and APP23 mice (n = 10 per group, 5 males and 5 females) were sacrificed at 3, 6, 9, 12, 18, 24 months of age.
The hippocampus formation of one hemisphere was isolated and homogenized in homogenization Immunostaining. Mice were perfused with 4% parafomaldehyde (PFA) buffered with 0.1M Phosphate Buffer. Serial sagittal sections (30 µm) were generated using a cryostat (Sigma).
Sections were penetrated with 0.15% Triton X-100 and were blocked with 10% horse or goat serum. 
